PRO

Floor & Decor Announces Grand Opening of Princeton, New Jersey Store

Retrieved on: 
Wednesday, November 15, 2023
Interior Design, Retail, Architecture, Home Goods, Residential Building & Real Estate, Specialty, Construction & Property, New York Jets, NYSE, RSVP, Commerce, MetLife Stadium, PRO, Family, Life, Floor & Decor, Interior design, Floor

PROs can visit www.flooranddecor.com/princetonpro to RSVP and register to win $10,000 and other great prizes like Floor & Decor gift cards and more.

Key Points: 
  • PROs can visit www.flooranddecor.com/princetonpro to RSVP and register to win $10,000 and other great prizes like Floor & Decor gift cards and more.
  • In addition, the Princeton Floor and Decor store gave away a $5,000 Floor Makeover and four tickets to the New York Giants vs. the New York Jets as part of its grand opening festivities.
  • Floor & Decor is one of Fortune's 100 fastest-growing companies, and in April 2023, Floor & Decor was named to Yelp’s “Most Loved Brands” list, which honors the most-loved brands on the consumer reviews platform.
  • For more information on Floor & Decor, please visit https://www.flooranddecor.com/ and on Facebook ( www.facebook.com/flooranddecor ).

Theragun Black Friday (2023): Summary of Early Offers Shared by Consumer Articles

Retrieved on: 
Sunday, November 12, 2023
Online Retail, Retail, Luxury, Other Retail, Home Goods, Specialty, Massage, Mini, Athlete, PRO, Microsoft Plus!, Sense, Walmart, Relaxation, Elite

Consumer Articles earns commissions from purchases made using the links provided.

Key Points: 
  • Consumer Articles earns commissions from purchases made using the links provided.
  • Theragun, a flagship product from Therabody, has earned a stellar reputation as a versatile percussive massager.
  • This family of massage gun devices offers a range of options to cater to various needs.
  • As Black Friday 2023 approaches on November 24, consumers interested in the massage gun category have reason to be excited.

EMA and European Organisation for Research and Treatment of Cancer (EORTC) workshop: How can patient-reported outcomes (PRO) and health-related quality of life (HRQoL) data inform regulatory decisions?, European Medicines Agency, Amsterdam, the Nethe[...]

Retrieved on: 
Monday, December 18, 2023
Location, EORTC, European Medicines Agency, Treatment, Pros, Quality of life (healthcare), EMA, Patient, Research, PRO, Facilitation, HRQOL, Industry, Medical device, Cancer

Date

Key Points: 
  • Date
    - Thursday, 29 February 2024
    Location
    - European Medicines Agency, Amsterdam, the Netherlands
    Event summary
    The European Medicines Agency (EMA) and the European Organisation for Research and Treatment of Cancer (EORTC) are jointly organising a workshop on how patient-reported outcomes (PRO) as well as health-related quality of life (HRQoL) data can inform regulatory decisions (please see the draft agenda attached).
  • This workshop will bring together international experts from academia, learned societies, patients, regulatory agencies, health technology assessment bodies, and industry.
  • The aims of the workshop are to:
    - Understand the current global landscape on the use of PROs and HRQOL for evaluation of anti-cancer treatments across different stakeholder groups.
  • - Understand the use of validated PRO questionnaires to measure core HRQOL outcomes and disease-related symptoms; and PRO Item Libraries in the development of trial-specific/treatment-specific item lists.

LSINC to sell in the Middle East through new partnership with PRO TECHnology

Retrieved on: 
Thursday, December 7, 2023
Creativity, UV, PRO, Perion Network, Partnership, 3D printing, MENA

PRO TECHnology, based in Dubai, the United Arab Emirates, will be LSINC's exclusive dealer in the region, selling and servicing the LSINC line of printers that print directly on cylindrical and tapered objects.

Key Points: 
  • PRO TECHnology, based in Dubai, the United Arab Emirates, will be LSINC's exclusive dealer in the region, selling and servicing the LSINC line of printers that print directly on cylindrical and tapered objects.
  • "We set a goal of taking our printers worldwide, and PRO TECHnology is absolutely the partner we want in the MENA region!
  • Jamal Maraqa, Founder and Managing Director of PRO TECHnology, expressed his enthusiasm about the collaboration and the innovative solutions LSINC brings to the table.
  • LSINC and PRO TECHnology will be together presenting the latest in printing technology at FESPA Middle East at the Dubai Exhibition Centre on January 29-31, 2024.

SUNMI officially launches Android flagship product T3 PRO Series, creating extraordinary user experience.

Retrieved on: 
Thursday, November 16, 2023
ID, Memory, Internet of things, Android, Engineering, Seiko, Point of sale, Multimedia, Internet, Wi-Fi 6, RAM, PRO, NFC, POS, Mobile phone

SHANGHAI, Nov. 15, 2023 /PRNewswire/ -- SUNMI, a leading IoT (Internet of Things) company, officially launched its 3rd generation Android flagship product, the T3 PRO and T3 PRO MAX.

Key Points: 
  • SHANGHAI, Nov. 15, 2023 /PRNewswire/ -- SUNMI, a leading IoT (Internet of Things) company, officially launched its 3rd generation Android flagship product, the T3 PRO and T3 PRO MAX.
  • As the highest-performance flagship device for Android, SUNMI T3 PRO series integrates SUNMI's distinctive design style, with ultimate appearance design and quality craftsmanship, providing customers with customized deployment solutions and extraordinary user experience.
  • SUNMI T3 PRO series define the flagship Android desktop standard with its powerful performance.
  • Of course, as the flagship product, it is worth mentioning the top industrial design with pioneering in engineering of T3 PRO.

e2e Pharma Realizes the Benefits of InstantGMP PRO™ All-In-One Software

Retrieved on: 
Wednesday, November 15, 2023
GMP, Education, SOP, Equipment, Good manufacturing practice, Beauty, Clinical Global Impression, CMOS, MPR, Health, Cosmetics, PRO, BPR, Software, CMO, Communication, Contract manufacturing organization, Good, Fine chemical, Medical device, Warehouse, Asset management, Risk management

CARY, N.C., Nov. 15, 2023 /PRNewswire-PRWeb/ -- InstantGMP™, the industry frontrunner in electronic batch record, quality management, and inventory management software solutions, proudly commemorates two years of support to e2e Pharma, a distinguished Arizona-based Contract Manufacturing Organization (CMO).

Key Points: 
  • A leader in white-label and private-label contract manufacturing across diverse industries, including health, wellness, beauty, cosmetics, and pet products, e2e Pharma continues to benefit immensely from the innovative InstantGMP PRO™ software system.
  • With InstantGMP PRO, e2e Pharma and similar CMOs can improve their manufacturing processes and overall customer experience.
  • Key Benefits of InstantGMP PRO for e2e Pharma and Similar CMOs:
    Streamlined MPR, BPR, and SOP Creation: InstantGMP PRO simplifies the creation of Master Production Records (MPR), Batch Production Records (BPR), and Standard Operating Procedures (SOP).
  • InstantGMP takes immense pride in supporting e2e Pharma's operational excellence by implementing our all-in-one manufacturing, inventory, and quality system.

TARGET-NASH Offers Unprecedented Glimpse into Growing Public Health Concerns with Few Treatment Options

Retrieved on: 
Monday, November 13, 2023
Calibration, Hepatology, Research, Entrepreneurship, AASLD, Liver disease, Fatty liver disease, Patient, Metabolism, Liver, Cirrhosis, PRO, MASH, American Heart, Target, Public, RWE, American Heart Association, Dietary supplement, Medical imaging, Pharmaceutical industry, Boston

DURHAM, N.C., Nov. 13, 2023 /PRNewswire/ -- In response to the growing unmet need for real-world evidence (RWE) surrounding metabolic liver diseases, industry leader Target RWE released new updates on TARGET-NASH, one of the largest real-world datasets of its kind.

Key Points: 
  • 15% have been treated or are currently being treated with a GLP-1 receptor agonist.
  • The TARGET-NASH longitudinal registry has enrolled more than 7,000 patients in the U.S. and Europe, with approximately 750 pediatric patients.
  • "Metabolic liver diseases are some of the most concerning public health concerns facing populations around the world.
  • Until now, stakeholders had little access to treatment patterns for this complex patient population being treated for multiple co-morbidities."

Global Healthy Living Foundation to Present Pioneering Patient-Centered Research at ACR Convergence 2023

Retrieved on: 
Thursday, November 9, 2023
Biometrics, Telemedicine, Virtual Medicine, Pharmaceutical, General Health, Health, Wearables, Mobile Technology, Technology, Other Health, Online, Rheumatism, American College, Hospital, Treatment, Face, Doctor of Philosophy, Medicine, Disease, Efficacy, COVID-19, Overalls, Culture, PRO, Pain, Medical Affairs Bureau, Gold, MPH, Impact, Additive effect, RA, American College of Rheumatology, Data management, Exercise, Patient, ACR, Plant, Rehabilitation, MD, Motivation, Mindfulness, Quality of life, Longitudinal study, Research, Osteoporosis, DSM-IV codes, Guideline, Rheumatoid arthritis, Role, TNF inhibitor, Pros, Conjoint analysis, Jaki, Poster, Ageing, WEAR, Pharmaceutical industry, Medical device, Medical imaging, Nursing, Dietary supplement, Diet, Rheumatology, Fatigue, Flare, Epidemiology, Arthritis

The Global Healthy Living Foundation and its digital, arthritis patient centered research registry, formerly ArthritisPower, will collaboratively present eight scientific abstracts and five patient perspective posters at the American College of Rheumatology Convergence 2023 (Philadelphia, PA, November 10-15, 2023).

Key Points: 
  • The Global Healthy Living Foundation and its digital, arthritis patient centered research registry, formerly ArthritisPower, will collaboratively present eight scientific abstracts and five patient perspective posters at the American College of Rheumatology Convergence 2023 (Philadelphia, PA, November 10-15, 2023).
  • Collectively, GHLF researchers will focus on innovative approaches to remote therapeutic monitoring, patient engagement, and personalized care in rheumatic and musculoskeletal diseases.
  • This study offers key insights on innovative disease tracking methods, including those that can happen outside traditional clinical settings, particularly for diseases like rheumatoid arthritis (RA).
  • GHLF anticipates engaging with fellow organizations and professionals at ACR Convergence to share their year-long accomplishments in rheumatic disease research.

Suvoda eCOA Earns High Marks in Patient Usability Study

Retrieved on: 
Thursday, November 9, 2023
FDA, Smartphone, IRT, Reading, American Opportunity Tax Credit, Data collection, Certification, Doctor of Philosophy, CNS, Patient, ISPOR, Software, Nature, Usability, PRO, Central nervous system, Medical device, Nursing

PHILADELPHIA, Nov. 9, 2023 /PRNewswire/ -- Suvoda LLC, a leading global clinical trial technology company specializing in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, has successfully conducted usability testing of its electronic clinical outcomes assessment (eCOA) solution in collaboration with RWS Life Sciences. The study resulted in the certification of Suvoda eCOA as highly usable and effective for the patient population.

Key Points: 
  • The study resulted in the certification of Suvoda eCOA as highly usable and effective for the patient population.
  • Suvoda announced the general availability of its eCOA product in May 2023 to address the difficulties and delays associated with traditional eCOA products.
  • And, because Suvoda eCOA, IRT, and eConsent are delivered on a single platform, study teams benefit from improved data integrity.
  • "This study validates that our eCOA solution makes it easy and efficient to obtain quality patient outcomes data for submissions and approvals."

Suvoda eCOA Earns High Marks in Patient Usability Study

Retrieved on: 
Thursday, November 9, 2023
FDA, Smartphone, IRT, Reading, American Opportunity Tax Credit, Data collection, Certification, Doctor of Philosophy, CNS, Patient, ISPOR, Software, Nature, Usability, PRO, Central nervous system, Medical device, Nursing

PHILADELPHIA, Nov. 9, 2023 /PRNewswire/ -- Suvoda LLC, a leading global clinical trial technology company specializing in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, has successfully conducted usability testing of its electronic clinical outcomes assessment (eCOA) solution in collaboration with RWS Life Sciences. The study resulted in the certification of Suvoda eCOA as highly usable and effective for the patient population.

Key Points: 
  • The study resulted in the certification of Suvoda eCOA as highly usable and effective for the patient population.
  • Suvoda announced the general availability of its eCOA product in May 2023 to address the difficulties and delays associated with traditional eCOA products.
  • And, because Suvoda eCOA, IRT, and eConsent are delivered on a single platform, study teams benefit from improved data integrity.
  • "This study validates that our eCOA solution makes it easy and efficient to obtain quality patient outcomes data for submissions and approvals."